Acrivon Therapeutics, Inc.
ACRV · Pharmaceutical Preparations · 42.8M shares · +169%/yr ↑ dilution · EDGAR filings ↗
Reference price $1.68 · est. market cap ~$72M — last insider purchase, 2026-01-14 (estimated from the dated SEC Form 4 price × shares outstanding — not a live quote)
Grade
D44Clinical/early-stage biotech — oncology clinical, well-funded.
Strengths
- Liquidity — current ratio 7.7 (72nd)
Risks
- Pre-revenue, deep losses — per metrics
- Pre-revenue/clinical-stage — history of losses & need for capital per risk factors
- Binary clinical & funding risk — per 10-K
Notable findings
- Exec changeRecent 8-K item 5.02 8-K ↗
- Cash burnNegative free cash flow (-65.3M)
- Fund exitedNotable fund(s) exited this quarter: VANGUARD GROUP INC, CITADEL ADVISORS LLC
- Chronic dilutionShare count +169%/yr over 3y (dilution, book value/share -97%)
- Insider buyingInsider buying — 3 open-market buy(s) by 3 insider(s) (cluster of 3 insiders, ~$114,341, last 6mo) Form 4 ↗
- Notable holderHeld by 4 notable fund(s): RENAISSANCE TECHNOLOGIES LLC, STATE STREET CORP, GOLDMAN SACHS GROUP INC +1 more (as of 2026-03-31)
Key metrics
Return on equity
-69.2%
Return on assets
-60.1%
Current ratio
7.7×
Free cash flow
-$65M
Tangible book value
$113M
Cash & investments
$119M
Cash runway
7q
Insider transactions · last 18 months
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| 2026-05-21 | Blume-Jensen Peter | Tax withheld | 14K | $1.79 |
| 2026-05-18 | TOMSICEK MICHAEL JOHN | Grant | 9.4K | — |
| 2026-05-18 | RA CAPITAL MANAGEMENT, L.P. | Grant | 9.4K | — |
| 2026-05-18 | Shacham Sharon | Grant | 9.4K | — |
| 2026-05-18 | Palani Santhosh | Grant | 9.4K | — |
| 2026-05-18 | Magovcevic-Liebisch Ivana | Grant | 9.4K | — |
| 2026-05-18 | DiRocco Derek | Grant | 9.4K | — |
| 2026-05-18 | BAUM CHARLES M | Grant | 9.4K | — |
| 2026-05-18 | Peterson Katharine | Grant | 14K | — |
| 2026-05-18 | Mirza Mansoor Raza | Grant | 39K | — |
| 2026-05-18 | Miller Mary | Grant | 50K | — |
| 2026-05-18 | Levy Adam D. | Grant | 46K | — |
| 2026-05-18 | Gamelin Erick | Grant | 39K | — |
| 2026-05-18 | Devroe Eric | Grant | 73K | — |
| 2026-05-18 | Blume-Jensen Peter | Grant | 180K | — |
| 2026-05-18 | Blume-Jensen Peter | Grant | 73K | — |
| 2026-05-14 | Gamelin Erick | Tax withheld | 404 | $1.92 |
| 2026-05-14 | Peterson Katharine | Tax withheld | 99 | $1.92 |
| 2026-05-14 | Miller Mary | Tax withheld | 184 | $1.92 |
| 2026-05-14 | Devroe Eric | Tax withheld | 613 | $1.92 |
| 2026-05-14 | Blume-Jensen Peter | Tax withheld | 1.3K | $1.92 |
| 2026-05-14 | Blume-Jensen Peter | Tax withheld | 490 | $1.92 |
| 2026-04-22 | RA CAPITAL MANAGEMENT, L.P. | Grant | 3.9M | $1.80 |
| 2026-04-17 | Miller Mary | Tax withheld | 558 | $1.78 |
| 2026-02-21 | Blume-Jensen Peter | Tax withheld | 14K | $1.53 |
| 2026-02-14 | Peterson Katharine | Tax withheld | 116 | $1.63 |
| 2026-02-14 | Miller Mary | Tax withheld | 217 | $1.63 |
| 2026-02-14 | Gamelin Erick | Tax withheld | 471 | $1.63 |
| 2026-02-14 | Devroe Eric | Tax withheld | 723 | $1.63 |
| 2026-02-14 | Blume-Jensen Peter | Tax withheld | 1.3K | $1.63 |
| 2026-02-14 | Blume-Jensen Peter | Tax withheld | 579 | $1.63 |
| 2026-01-17 | Miller Mary | Tax withheld | 659 | $1.98 |
| 2026-01-14 | Blume-Jensen Peter | Buy | 49K | $1.68 |
| 2026-01-14 | Levy Adam D. | Buy | 8.8K | $1.70 |
| 2026-01-13 | Devroe Eric | Buy | 10K | $1.72 |
| 2025-11-21 | Blume-Jensen Peter | Tax withheld | 20K | $2.30 |
| 2025-11-14 | Miller Mary | Tax withheld | 184 | $2.24 |
| 2025-11-14 | Peterson Katharine | Tax withheld | 99 | $2.24 |
| 2025-11-14 | Gamelin Erick | Tax withheld | 403 | $2.24 |
| 2025-11-14 | Devroe Eric | Tax withheld | 613 | $2.24 |
| 2025-11-14 | Blume-Jensen Peter | Tax withheld | 60K | $2.24 |
| 2025-11-14 | Blume-Jensen Peter | Tax withheld | 490 | $2.24 |
| 2025-10-17 | Miller Mary | Tax withheld | 558 | $1.81 |
| 2025-10-01 | Miller Mary | Tax withheld | 284 | $1.81 |
| 2025-08-21 | Blume-Jensen Peter | Tax withheld | 20K | $1.32 |
| 2025-08-14 | Gamelin Erick | Tax withheld | 403 | $1.39 |
| 2025-08-14 | Blume-Jensen Peter | Tax withheld | 60K | $1.39 |
| 2025-08-14 | Blume-Jensen Peter | Tax withheld | 490 | $1.39 |
| 2025-08-14 | Devroe Eric | Tax withheld | 613 | $1.39 |
| 2025-08-14 | Peterson Katharine | Tax withheld | 99 | $1.39 |
| 2025-08-14 | Miller Mary | Tax withheld | 184 | $1.39 |
| 2025-08-01 | Levy Adam D. | Tax withheld | 1.2K | $1.26 |
| 2025-07-17 | Miller Mary | Tax withheld | 558 | $1.32 |
| 2025-05-21 | Blume-Jensen Peter | Tax withheld | 20K | $1.15 |
| 2025-05-14 | Blume-Jensen Peter | Tax withheld | 60K | $1.14 |
| 2025-05-14 | Peterson Katharine | Tax withheld | 99 | $1.14 |
| 2025-05-14 | Miller Mary | Tax withheld | 184 | $1.14 |
| 2025-05-14 | Gamelin Erick | Tax withheld | 403 | $1.14 |
| 2025-05-14 | Devroe Eric | Tax withheld | 613 | $1.14 |
| 2025-05-14 | Blume-Jensen Peter | Tax withheld | 491 | $1.14 |
| 2025-05-01 | PERCEPTIVE ADVISORS LLC | Sell | 299K | $1.34 |
| 2025-04-30 | PERCEPTIVE ADVISORS LLC | Sell | 438K | $1.41 |
| 2025-04-29 | PERCEPTIVE ADVISORS LLC | Sell | 250K | $1.41 |
| 2025-04-28 | PERCEPTIVE ADVISORS LLC | Sell | 215K | $1.56 |
| 2025-04-25 | PERCEPTIVE ADVISORS LLC | Sell | 1.1M | $1.95 |
| 2025-04-17 | Miller Mary | Tax withheld | 558 | $1.81 |
| 2025-02-21 | Blume-Jensen Peter | Tax withheld | 20K | $5.54 |
| 2025-02-14 | Peterson Katharine | Tax withheld | 116 | $5.42 |
| 2025-02-14 | Miller Mary | Tax withheld | 217 | $5.42 |
| 2025-02-14 | Holm-Jorgensen Rasmus | Tax withheld | 434 | $5.42 |
| 2025-02-14 | Gamelin Erick | Tax withheld | 469 | $5.42 |
| 2025-02-14 | Devroe Eric | Tax withheld | 724 | $5.42 |
| 2025-02-14 | Blume-Jensen Peter | Tax withheld | 37K | $5.42 |
| 2025-02-14 | Blume-Jensen Peter | Tax withheld | 579 | $5.42 |
| 2025-01-17 | Miller Mary | Tax withheld | 659 | $5.78 |
All non-derivative Form 4 activity (SEC), newest first.
Notable events (8-K)
| Date | Items | |
|---|---|---|
| 2026-06-17 | Exec/director changeShareholder voteExhibits | filing ↗ |
| 2026-05-13 | ResultsExhibits | filing ↗ |
| 2026-03-19 | ResultsReg FDExhibits | filing ↗ |
| 2026-03-02 | 1.02 | filing ↗ |
| 2026-02-27 | Reg FDExhibits | filing ↗ |
| 2026-01-08 | ResultsReg FDOtherExhibits | filing ↗ |
| 2026-01-08 | Reg FDExhibits | filing ↗ |
| 2025-11-13 | ResultsExhibits | filing ↗ |
Recent filings
| Form | Filed | Period | Accession |
|---|---|---|---|
| 8-K | 2026-06-17 | 2026-06-17 | 0001193125-26-274410 ↗ |
| 10-Q | 2026-05-13 | 2026-03-31 | 0001193125-26-221634 ↗ |
| 8-K | 2026-05-13 | 2026-05-13 | 0001193125-26-221626 ↗ |
| 8-K | 2026-03-19 | 2026-03-19 | 0001193125-26-115139 ↗ |
| 10-K | 2026-03-19 | 2025-12-31 | 0001193125-26-115123 ↗ |
| 8-K | 2026-03-02 | 2026-02-25 | 0001193125-26-085516 ↗ |
| 8-K | 2026-02-27 | 2026-02-27 | 0001193125-26-079500 ↗ |
| 8-K | 2026-01-08 | 2026-01-08 | 0001193125-26-007007 ↗ |
| 8-K | 2026-01-08 | 2026-01-08 | 0001193125-26-007077 ↗ |
| 10-Q | 2025-11-13 | 2025-09-30 | 0001193125-25-280215 ↗ |
| 8-K | 2025-11-13 | 2025-11-13 | 0001193125-25-280172 ↗ |
| 8-K | 2025-09-05 | 2025-09-05 | 0001193125-25-197250 ↗ |